Article
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
20 Jun 2024
Abstract excerpt
BACKGROUND: Breast cancer (BC) is a heterogeneous neoplasm characterized by several subtypes. One of the most aggressive with high metastasis rates presents overexpression of the human epidermal growth factor receptor 2 (HER2). A quantitative evaluation of HER2 levels is essential for a correct diagnosis, selection of the most appropriate therapeutic strategy and monitoring the response to therapy. RESULTS: In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
